Single-dose Intravenous-administration of Recombinant Human Erythropoietin Considerably Improved Cardiac Function in Patients With Acute Myocardial Infarction: A Randomized Controlled Pilot Trial of EPO/AMI-I Study

被引:0
|
作者
Ozawa, Takuya [1 ]
Toba, Ken [1 ]
Kato, Kiminori [1 ]
Suzuki, Hiroshi [2 ]
Iso, Yoshitaka [2 ]
Kobayashi, Naohiko [3 ]
Akutsu, Yasushi [4 ]
Takayama, Tsugumi [1 ]
Yanagawa, Takao [1 ]
Yoshimura, Norihiko [1 ]
Kobayashi, Youichi [4 ]
Takeyama, Youichi [2 ]
Akazawa, Kohei [1 ]
Aizawa, Yoshifusa [1 ]
机构
[1] Niigata Univ, Med & Dent Hosp, Niigata, Japan
[2] Showa Univ, Fujigaoka Hosp, Yokohama, Kanagawa 227, Japan
[3] Dokkyo Univ, Sch Med, Mibu, Tochigi, Japan
[4] Showa Univ, Sch Med, Tokyo 142, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S1173 / S1174
页数:2
相关论文
共 10 条
  • [1] Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction - Randomized Controlled Pilot Trial of EPO/AMI-1 Study
    Ozawa, Takuya
    Toba, Ken
    Suzuki, Hiroshi
    Kato, Kiminori
    Iso, Yoshitaka
    Akutsu, Yasushi
    Kobayashi, Youichi
    Takeyama, Youichi
    Kobayashi, Naohiko
    Yoshimura, Norihiko
    Akazawa, Kohei
    Aizawa, Yoshifusa
    CIRCULATION JOURNAL, 2010, 74 (07) : 1415 - 1423
  • [2] A Novel Program to Accurately Quantify Infarction Volume by 99mTc MIBI SPECT, and Its Application for Re-Analyzing the Effect of Erythropoietin Administration in Patients With Acute Myocardial Infarction - A Randomized Controlled Pilot Trial of the EPO/AMI-I Study
    Yoshimura, Norihiko
    Toba, Ken
    Ozawa, Takuya
    Aizawa, Yoshifusa
    Hosoya, Tetsuo
    CIRCULATION JOURNAL, 2010, 74 (12) : 2741 - 2743
  • [3] Low-Dose Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction (EPO-AMI-II) - A Randomized Controlled Clinical Trial
    Minamino, Tetsuo
    Higo, Shuichiro
    Araki, Ryo
    Hikoso, Shungo
    Nakatani, Daisaku
    Suzuki, Hiroshi
    Yamada, Takahisa
    Okutsu, Masaaki
    Yamamoto, Kouji
    Fujio, Yasushi
    Ishida, Yoshio
    Ozawa, Takuya
    Kato, Kiminori
    Toba, Ken
    Aizawa, Yoshifusa
    Komuro, Issei
    CIRCULATION JOURNAL, 2018, 82 (04) : 1083 - +
  • [4] Design and Rationale of Low-Dose Erythropoietin in Patients with ST-Segment Elevation Myocardial Infarction (EPO-AMI-II Study): A Randomized Controlled Clinical Trial
    Minamino, Tetsuo
    Toba, Ken
    Higo, Shuichiro
    Nakatani, Daisaku
    Hikoso, Shungo
    Umegaki, Masao
    Yamamoto, Kouji
    Sawa, Yoshiki
    Aizawa, Yoshifusa
    Komuro, Issei
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (05) : 409 - 416
  • [5] Design and Rationale of Low-Dose Erythropoietin in Patients with ST-Segment Elevation Myocardial Infarction (EPO-AMI-II Study): A Randomized Controlled Clinical Trial
    Tetsuo Minamino
    Ken Toba
    Shuichiro Higo
    Daisaku Nakatani
    Shungo Hikoso
    Masao Umegaki
    Kouji Yamamoto
    Yoshiki Sawa
    Yoshifusa Aizawa
    Issei Komuro
    Cardiovascular Drugs and Therapy, 2012, 26 : 409 - 416
  • [6] Erythropoietin Prevention Trial of Coronary Restenosis and Cardiac Remodeling After ST-Elevated Acute Myocardial Infarction (EPOC-AMI) - A Pilot, Randomized, Placebo-Controlled Study
    Taniguchi, Norimasa
    Nakamura, Takeshi
    Sawada, Takahisa
    Matsubara, Kinya
    Furukawa, Keizo
    Hadase, Mitsuyoshi
    Nakahara, Yoshifumi
    Nakamura, Takashi
    Matsubara, Hiroaki
    CIRCULATION JOURNAL, 2010, 74 (11) : 2365 - 2371
  • [7] Rationale and Design of a Randomized Controlled Pilot Trial to Assess Stent Retriever Thrombectomy for Thrombus Burden Reduction in Patients with Acute Myocardial Infarction: The RETRIEVE-AMI Study
    Kotronias, Rafail A.
    Marin, Federico
    Emfietzoglou, Maria
    Langrish, Jeremy P.
    Lucking, Andrew J.
    Channon, Keith M.
    Banning, Adrian P.
    De Maria, Giovanni Luigi
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 52 : 75 - 85
  • [8] Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: a sub-study of the randomized placebo-controlled PACMAN-AMI trial
    Rexhaj, E.
    Soria, R.
    Baer, S.
    Kavaliauskaite, R.
    Yasushi, U.
    Tatsuhiko, O.
    Temperli, F.
    Shibutani, H.
    Siontis, G.
    Haener D, J.
    Stortecky, S.
    Windecker, S.
    Koskinas C, K.
    Losdat, S.
    Raeber, L.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1398 - 1398
  • [9] A single-center prospective randomized controlled trial evaluating the safety and efficacy of IntraCoronary Erythropoietin delivery BEfore Reperfusion: Gauging infarct size in patients with acute ST-segment elevation myocardial infarction. Study design and rationale of the 'ICEBERG Trial'
    Suh, Jung-Won
    Yoon, Yeonyee E.
    Oh, Il-Young
    Yoon, Chang-Hwan
    Cho, Young-Seok
    Youn, Tae-Jin
    Chae, In-Ho
    Choi, Dong-Ju
    CONTEMPORARY CLINICAL TRIALS, 2013, 35 (01) : 145 - 150
  • [10] A phase II randomized, placebo-controlled, single-blind, multi-center dose-escalation study to evaluate tolerability, safety, pharmacokinetics, and pharimacodynamics of a single intravenous administration of INO-1001 in subjects with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention: Results of the TIMI 37A trial
    Morrow, David A.
    Baran, Kenneth
    Krakover, Ricardo
    Dauerman, Harold
    Murphy, Sabina A.
    Kumar, Sujatha
    McCabe, Carolyn H.
    Brickman, Chaim M.
    Salzman, Andrew L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 202A - 202A